ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 167 filers reported holding ANIKA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,698,885 | -25.6% | 305,860 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $7,661,042 | -6.3% | 294,882 | +3.6% | 0.00% | 0.0% |
| Q1 2023 | $8,175,588 | +100115.6% | 284,665 | +3.3% | 0.00% | 0.0% |
| Q4 2022 | $8,158 | -99.9% | 275,622 | +4.3% | 0.00% | 0.0% |
| Q3 2022 | $6,287,000 | +7.8% | 264,201 | +1.1% | 0.00% | 0.0% |
| Q2 2022 | $5,832,000 | -8.4% | 261,322 | +3.1% | 0.00% | 0.0% |
| Q1 2022 | $6,367,000 | -31.5% | 253,580 | -2.2% | 0.00% | 0.0% |
| Q4 2021 | $9,294,000 | -15.6% | 259,393 | +0.3% | 0.00% | 0.0% |
| Q3 2021 | $11,008,000 | -0.3% | 258,663 | +1.4% | 0.00% | -50.0% |
| Q2 2021 | $11,041,000 | +11.7% | 255,050 | +5.2% | 0.00% | 0.0% |
| Q1 2021 | $9,888,000 | +2.6% | 242,413 | +13.8% | 0.00% | 0.0% |
| Q4 2020 | $9,640,000 | +30.3% | 213,001 | +1.9% | 0.00% | +100.0% |
| Q3 2020 | $7,400,000 | -15.5% | 209,112 | -9.9% | 0.00% | -50.0% |
| Q2 2020 | $8,758,000 | +41.7% | 232,129 | +8.6% | 0.00% | 0.0% |
| Q1 2020 | $6,180,000 | -73.3% | 213,767 | -52.0% | 0.00% | 0.0% |
| Q4 2019 | $23,108,000 | +90.9% | 445,708 | +102.1% | 0.00% | -33.3% |
| Q3 2019 | $12,104,000 | +36.3% | 220,522 | +0.8% | 0.00% | +50.0% |
| Q2 2019 | $8,883,000 | +48.6% | 218,686 | +10.6% | 0.00% | 0.0% |
| Q1 2019 | $5,976,000 | -50.1% | 197,654 | -44.6% | 0.00% | 0.0% |
| Q4 2018 | $11,980,000 | +65.2% | 356,468 | +107.4% | 0.00% | 0.0% |
| Q3 2018 | $7,250,000 | +35.3% | 171,905 | +2.6% | 0.00% | 0.0% |
| Q2 2018 | $5,359,000 | -22.7% | 167,514 | +20.1% | 0.00% | 0.0% |
| Q1 2018 | $6,934,000 | -5.7% | 139,478 | +2.2% | 0.00% | 0.0% |
| Q4 2017 | $7,356,000 | -4.3% | 136,468 | +2.9% | 0.00% | -33.3% |
| Q3 2017 | $7,688,000 | +24.7% | 132,562 | +6.1% | 0.00% | +50.0% |
| Q2 2017 | $6,163,000 | +21.2% | 124,913 | +6.7% | 0.00% | 0.0% |
| Q1 2017 | $5,084,000 | -13.6% | 117,036 | -2.6% | 0.00% | -33.3% |
| Q4 2016 | $5,883,000 | -0.5% | 120,164 | -2.8% | 0.00% | 0.0% |
| Q3 2016 | $5,914,000 | -1.4% | 123,618 | +10.5% | 0.00% | 0.0% |
| Q2 2016 | $5,999,000 | +23.5% | 111,844 | +3.0% | 0.00% | 0.0% |
| Q1 2016 | $4,856,000 | +33.3% | 108,619 | +13.7% | 0.00% | +50.0% |
| Q4 2015 | $3,644,000 | +22.2% | 95,493 | +1.9% | 0.00% | 0.0% |
| Q3 2015 | $2,983,000 | -2.8% | 93,720 | +0.9% | 0.00% | 0.0% |
| Q2 2015 | $3,068,000 | -14.2% | 92,910 | +7.0% | 0.00% | 0.0% |
| Q1 2015 | $3,574,000 | +17.6% | 86,833 | +16.4% | 0.00% | 0.0% |
| Q4 2014 | $3,039,000 | -0.9% | 74,615 | -10.8% | 0.00% | 0.0% |
| Q3 2014 | $3,067,000 | -20.0% | 83,666 | +1.1% | 0.00% | 0.0% |
| Q2 2014 | $3,832,000 | +26.7% | 82,723 | +12.4% | 0.00% | 0.0% |
| Q1 2014 | $3,025,000 | -27.6% | 73,607 | -32.7% | 0.00% | -33.3% |
| Q4 2013 | $4,176,000 | +221.0% | 109,436 | +101.5% | 0.00% | +200.0% |
| Q3 2013 | $1,301,000 | +48.5% | 54,304 | +5.4% | 0.00% | 0.0% |
| Q2 2013 | $876,000 | – | 51,522 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
| Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
| CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
| Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
| Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
| DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
| Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
| Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
| Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |